Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of synthetic method of Sofosbuvir intermediate

A synthetic method and intermediate technology, applied in the field of synthesis of pharmaceutical intermediates, can solve the problems of not being able to adapt to large-scale industrial production, poor stereoselectivity, and low yield, and achieve good application prospects and market potential, simple steps, and low cost. cheap effect

Active Publication Date: 2019-05-14
ANHUI TWISUN HI TECH PHARM CO LTD
View PDF14 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] As for other methods for the synthesis of compound (I) disclosed in the prior art, they are often unable to adapt to large-scale industrial production because of the shortcomings of long route, low yield, and poor stereoselectivity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of synthetic method of Sofosbuvir intermediate
  • A kind of synthetic method of Sofosbuvir intermediate
  • A kind of synthetic method of Sofosbuvir intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The synthesis of embodiment 1 compound VI II

[0034]

[0035] Add 200 g of compound II and 1.0 L of ethanol into a 2 L reaction flask, stir and dissolve to form a clear solution. At room temperature, 200 g of acetic acid was slowly added dropwise. After the dropwise addition, the temperature of the reaction mixture was raised to 80° C., and the reaction was stirred for 15 hours. After the reaction was completed, it was concentrated under reduced pressure, and the solvent ethanol was distilled off. Then add 400mL of acetone, stir, and raise the temperature to 50°C. After a clear solution formed, 20 mL of water was slowly added dropwise. After the dropwise addition, the temperature was slowly lowered to 10° C., and crystallization was carried out with stirring. The solid formed was Buchner filtered and the filter cake was washed twice with pre-cooled acetone. The obtained solid was dried to obtain compound VIII (108 g, 82%). 1 H NMR (400MHz, DMSO-d6) δ: 5.81(s, ...

Embodiment 2

[0037] The synthesis of embodiment 2 compound IX

[0038]

[0039]Under the protection of nitrogen, 200 g of compound VIII, 1.0 L of 2-methyltetrahydrofuran and 390 g of pyridine were added into a 5.0 L reaction flask, stirred and dissolved to form a clear solution. The temperature of the reaction solution was lowered to 5° C., and 295 g of benzoyl chloride was slowly added dropwise. During the dropwise addition, the reaction temperature is controlled between 10-15°C. After the dropwise addition, the reaction solution was stirred and reacted at 15° C. for 30 minutes. After the completion of the reaction was confirmed by high performance liquid chromatography, 2.0 L of hydrochloric acid (6.0 N) and 5.0 L of dichloromethane were added. Stand to separate layers and take the organic phase. The aqueous phase was extracted twice with 2.0 L of dichloromethane. Combine the organic phases, wash once with 1.0L hydrochloric acid (1.0N), and wash twice with 1.0L saturated sodium bi...

Embodiment 3

[0041] The synthesis of embodiment 3 compound I

[0042]

[0043] Add 50 g of compound IX and 600 mL of acetonitrile into a 2.0 L reaction flask, stir and dissolve to form a clear solution. 100 mL of triethylamine trihydrofluoride and 68 g of triethylamine were added. The temperature of the reaction mixture was lowered to 0° C., and a solution of thionyl chloride (13.3 g) in acetonitrile (100 mL) was slowly added dropwise with stirring. After the dropwise addition, the temperature was maintained for 2 h. After the completion of the reaction was confirmed by high performance liquid chromatography, the reaction was also concentrated to dryness under reduced pressure. Add 250 mL of isopropanol to the obtained crude product, raise the temperature to 55°C, and stir to dissolve. Stirring was continued overnight during which time the temperature slowly fell to room temperature. Continue to cool down to 0°C and stir for one hour. The solid formed was Buchner filtered and the fi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention provides a synthetic method of a sofosbuvir intermediate, wherein the method, with a compound (II) as an initial raw material, includes the steps of: 1) performing a de-protective reaction and a cyclization reaction to the compound (II) to obtain an inter-product (VIII); 2) performing esterification to the inter-product (VIII) with benzoyl chloride to obtain an inter-product (IX); and 3) dissolving the inter-product (IX) in a solvent, and slowly adding dropwise a sulfonyl chloride solution in the presence of organic alkali and triethylamine trihydrofluoride, wherein in the reaction process, the compound (X) serves as an intermediate and is unnecessary to separate, so that a fluoronation reaction thereof can be completed directly in the reaction system, thereby producing the sofosbuvir intermediate.

Description

technical field [0001] The present invention relates to a kind of synthetic method of medicine intermediate, relate in particular to a kind of synthetic method of sofosbuvir intermediate. Background technique [0002] Sofosbuvir is an anti-hepatitis C patent drug newly developed by Gilead Sciences of the United States. Its chemical name is: (S)-2-[(((2R,3R,4R,5R)-5-(2,4-di Oxo-3,4-dihydropyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphorylamino]propionic acid Isopropyl ester, the structural formula is as follows: [0003] [0004] It is the first drug approved for an all-oral treatment regimen for hepatitis C. The product was approved by the US Food and Drug Administration in December 2013 and the European Union in January 2014. Sofosbuvir is currently regarded as a breakthrough drug for the treatment of hepatitis C, with a cure rate of over 90%. [0005] At the same time, sofosbuvir-based compound hepatitis C treatment methods, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D307/33
CPCC07D307/33
Inventor 叶敏龙双喜叶方国
Owner ANHUI TWISUN HI TECH PHARM CO LTD